A detailed history of Transatlantique Private Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Transatlantique Private Wealth LLC holds 6,171 shares of NVO stock, worth $633,329. This represents 0.29% of its overall portfolio holdings.

Number of Shares
6,171
Previous 5,976 3.26%
Holding current value
$633,329
Previous $853,000 13.95%
% of portfolio
0.29%
Previous 0.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $23,218 - $28,356
195 Added 3.26%
6,171 $734,000
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $53,133 - $63,612
-433 Reduced 6.76%
5,976 $853,000
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $12,865 - $17,125
126 Added 2.01%
6,409 $822,000
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $23,437 - $28,155
267 Added 4.44%
6,283 $649,000
Q3 2023

Jun 25, 2024

SELL
$90.94 - $199.54 $35,739 - $78,419
-393 Reduced 6.13%
6,016 $547,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $260,361 - $571,283
2,863 Added 90.8%
6,016 $547,000
Q2 2023

Jun 25, 2024

SELL
$155.98 - $172.65 $98,579 - $109,114
-632 Reduced 16.7%
3,153 $510,000
Q2 2023

Aug 10, 2023

SELL
$155.98 - $172.65 $98,579 - $109,114
-632 Reduced 16.7%
3,153 $510,000
Q1 2023

Jun 25, 2024

SELL
$132.34 - $159.14 $347,260 - $417,583
-2,624 Reduced 40.94%
3,785 $602,000
Q1 2023

May 05, 2023

BUY
$132.34 - $159.14 $64,317 - $77,342
486 Added 14.73%
3,785 $602,000
Q4 2022

Jun 25, 2024

SELL
$102.55 - $135.33 $318,930 - $420,876
-3,110 Reduced 48.53%
3,299 $446,000
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $338,312 - $446,453
3,299 New
3,299 $446,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Transatlantique Private Wealth LLC Portfolio

Follow Transatlantique Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transatlantique Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transatlantique Private Wealth LLC with notifications on news.